Product Code: 741
Global Coenzyme Q10 Market will witness over 10.5% CAGR between 2023 and 2032 due to burgeoning research and development in the field. With increased focus on health and wellness, studies revealing CoQ10's potential benefits in heart health, energy production, and antioxidant properties have sparked immense interest.
For instance, in November 2023, A recent review article titled "Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases," penned by a team of Iranian researchers and published in Biochemistry Research International, suggested that Coenzyme Q10 (CoQ10), an intrinsic antioxidant present in the body and certain foods, could potentially aid in treating conditions like Friedreich's ataxia and other neurological ailments. The researchers propose that CoQ10's antioxidative and energy-regulating properties might safeguard the neurological system from degeneration and decline.
This surge in exploration fuels demand, compelling industries to innovate and enhance CoQ10 formulations for wider applications. As scientific endeavors unravel its multifaceted advantages, the market growth trajectory aligns with the quest for improved health solutions in modern times.
The overall Coenzyme Q10 Market share is classified based on application and region.
Coenzyme Q10 market size from the pharmaceuticals segment will register a noteworthy CAGR from 2023 to 2032. Pharmaceutical industries value CoQ10 for its role in treating cardiovascular issues, neurological disorders, and potential applications in cancer treatment. With its antioxidant properties and involvement in cellular energy production, CoQ10 holds promise in enhancing drug formulations and supplementing various therapies. This escalating demand within pharmaceuticals reflects the continuous exploration and utilization of CoQ10 as a vital component in advancing medical interventions for improved health outcomes.
Asia Pacific coenzyme Q10 industry will showcase a commendable CAGR from 2023 to 2032. With rising awareness of preventive healthcare, there is a surge in CoQ10 consumption in dietary supplements and cosmetics. This trend is propelled by its antioxidant properties and purported benefits in heart health. Moreover, Asia Pacific's aging population seeks CoQ10 for its potential in addressing age-related health concerns.
This increasing demand reflects the region's inclination toward holistic health practices, driving the CoQ10 market growth across diverse industries. For instance, in August 2021, Kaneka Corporation, led by President Minoru Tanaka and headquartered in Minato-ku, Tokyo, declared that the active variant of Coenzyme Q10 demonstrates efficacy in alleviating transient fatigue. Recent functional claims endorse its ability to enhance sleep quality amidst temporary stress, reduce such stress, and aid in sustaining oral moisture. Consequently, Kaneka Your Health Care Co., Ltd., helmed by President Shoji Nagae and also based in Minato-ku, Tokyo, introduced a novel product line named "Watashi no ChikaraTM," featuring these functional benefits.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.2.1 Forecast calculations
- 1.3 Data Sources
- 1.3.1 Primary
- 1.3.2 Secondary
- 1.3.2.1 Paid Sources
- 1.3.2.2 Public Sources
Chapter 2 Executive Summary
- 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2023 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Application trend
Chapter 3 Global coenzyme Q10 Industry Insights
- 3.1 Industry segmentation
- 3.2 Impact of COVID-19 on world economy
- 3.3 Industry ecosystem analysis
- 3.3.1 Vendor matrix
- 3.3.2 Distribution channel analysis
- 3.3.2.1 Distributor
- 3.3.2.2 Suppliers
- 3.3.2.3 Contract Manufacturing
- 3.3.2.4 Technology providers
- 3.4 Raw material analysis: Covid-19 impact on supply
- 3.4.1 Covid-19 impact on supply
- 3.5 Industry landscape, 2018 - 2032
- 3.6 Technology landscape
- 3.7 Regulatory landscape
- 3.8 Pricing analysis
- 3.8.1.1 Regional pricing: COVID-19 impact
- 3.8.1.2 Cost structure analysis
- 3.9 Industry impact forces
- 3.9.1 Growth drivers
- 3.9.1.1 North America: Growing demand for cosmetics product
- 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
- 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
- 3.9.2 Industry pitfalls & challenges
- 3.9.2.1 Minimum dosage requirement
- 3.10 Innovation & sustainability
- 3.11 Growth potential analysis, 2022
- 3.11.1 Emerging business model
- 3.11.1.1 New Product Launch
- 3.11.1.2 Collaboration
- 3.12 Porter's analysis
- 3.12.1 Bargaining power of suppliers
- 3.12.2 Bargaining power of buyers
- 3.12.3 Threat of new entrants
- 3.12.4 Threat of substitutes
- 3.13 Competitive landscape, 2022
- 3.13.1 Company market share analysis, 2022
- 3.13.2 Top players overview
- 3.13.3 Strategy dashboard
- 3.14 PESTEL analysis
- 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
- 3.15.1 Dietary Supplements
- 3.15.2 Pharmaceuticals
- 3.15.3 Cosmetics
- 3.15.4 Others
Chapter 4 Global Coenzyme Q 10 Market, By Application
- 4.1 Key application trends
- 4.2 Pharmaceuticals
- 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
- 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2018 - 2032, (Tons) (USD Million)
- 4.3 Dietary Supplements
- 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
- 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2018 - 2032, (Tons) (USD Million)
- 4.4 Cosmetics
- 4.4.1 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
- 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2018 - 2032, (Tons) (USD Million)
- 4.5 Others
- 4.5.1 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
- 4.5.2 Global coenzyme Q10 market from other application, by region, 2018 - 2032, (Tons) (USD Million)
Chapter 5 Global Coenzyme Q 10 Market, By Region
- 5.1 Key regional trends
- 5.2 North America
- 5.2.1 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.2.2 North America coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.2.3 U.S.
- 5.2.3.1 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.2.3.2 U.S. coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.2.4 Canada
- 5.2.4.1 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.2.4.2 Canada coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3 Europe
- 5.3.1 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.2 Europe coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.3 Germany
- 5.3.3.1 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.3.2 Germany coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.4 UK
- 5.3.4.1 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.4.2 UK coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.5 France
- 5.3.5.1 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.5.2 France coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.6 Italy
- 5.3.6.1 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.6.2 Italy coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.7 Russia
- 5.3.7.1 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.7.2 Russia coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.3.8 Poland
- 5.3.8.1 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.3.8.2 Poland coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.4.3 China
- 5.4.3.1 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.4.3.2 China coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.4.4 India
- 5.4.4.1 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.4.4.2 India coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.4.5 Japan
- 5.4.5.1 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.4.5.2 Japan coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.5 Latin America (LATAM)
- 5.5.1 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.5.2 LATAM coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.5.3 Brazil
- 5.5.3.1 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.5.3.2 Brazil coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.5.4 Mexico
- 5.5.4.1 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.5.4.2 Mexico coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
- 5.6 Middle East & Africa (MEA)
- 5.6.1 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
- 5.6.2 MEA coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
Chapter 6 Company Profiles
- 6.1 Kaneka Corporation
- 6.1.1 Business Overview
- 6.1.2 Financial Data
- 6.1.3 Product Landscape
- 6.1.4 SWOT Analysis
- 6.2 DSM
- 6.2.1 Business Overview
- 6.2.2 Financial Data
- 6.2.3 Product Landscape
- 6.2.4 SWOT Analysis
- 6.3 SourceOne Global Partners, LLC
- 6.3.1 Business Overview
- 6.3.2 Financial Data
- 6.3.3 Product Landscape
- 6.3.4 SWOT Analysis
- 6.4 Healthy Origins
- 6.4.1 Business Overview
- 6.4.2 Financial Data
- 6.4.3 Product Landscape
- 6.4.4 SWOT Analysis
- 6.5 Vitamin Shoppe, Inc.
- 6.5.1 Business Overview
- 6.5.2 Financial Data
- 6.5.3 Product Landscape
- 6.5.4 SWOT Analysis
- 6.6 NBTY, Inc.
- 6.6.1 Business Overview
- 6.6.2 Financial Data
- 6.6.3 Product Landscape
- 6.6.4 SWOT Analysis
- 6.7 Pharmavite LLC
- 6.7.1 Business Overview
- 6.7.2 Financial Data
- 6.7.3 Product Landscape
- 6.7.4 SWOT Analysis
- 6.8 QUTEN Research Institute LLC
- 6.8.1 Business Overview
- 6.8.2 Financial Data
- 6.8.3 Product Landscape
- 6.8.4 SWOT Analysis
- 6.9 Tishcon Corp.
- 6.9.1 Business Overview
- 6.9.2 Financial Data
- 6.9.3 Product Landscape
- 6.9.4 SWOT Analysis
- 6.10 Country Life, LLC
- 6.10.1 Business Overview
- 6.10.2 Financial Data
- 6.10.3 Product Landscape
- 6.10.4 SWOT Analysis
- 6.11 Natural Organics
- 6.11.1 Business Overview
- 6.11.2 Financial Data
- 6.11.3 Product Landscape
- 6.11.4 SWOT Analysis
- 6.11.5 Strategic Outlook
- 6.12 Jarrow Formulas
- 6.12.1 Business Overview
- 6.12.2 Financial Data
- 6.12.3 Product Landscape
- 6.12.4 SWOT Analysis
- 6.13 NOW Foods
- 6.13.1 Business Overview
- 6.13.2 Financial Data
- 6.13.3 Product Landscape
- 6.13.4 SWOT Analysis
- 6.14 Pharma Nord, Inc.
- 6.14.1 Business Overview
- 6.14.2 Financial Data
- 6.14.3 Product Landscape
- 6.14.4 SWOT Analysis
- 6.15 Doctor's Best
- 6.15.1 Business Overview
- 6.15.2 Financial Data
- 6.15.3 Product Landscape
- 6.15.4 SWOT Analysis
- 6.15.5 Strategic Outlook
- 6.16 Xiamen Kingdomway Group
- 6.16.1 Business Overview
- 6.16.2 Financial Data
- 6.16.3 Product Landscape
- 6.16.4 SWOT Analysis
- 6.17 GNC Holdings, Inc.
- 6.17.1 Business Overview
- 6.17.2 Financial Data
- 6.17.3 Product Landscape
- 6.17.4 SWOT Analysis
- 6.18 Nordic Naturals, Inc.
- 6.18.1 Business Overview
- 6.18.2 Financial Data
- 6.18.3 Product Landscape
- 6.18.4 SWOT Analysis
Chapter 7 Potential Customers
- 7.1 Merck & Co.
- 7.1.1 Business Overview
- 7.1.2 Financial Data
- 7.1.3 Product Landscape
- 7.2 Abbott Laboratories
- 7.2.1 Business Overview
- 7.2.2 Financial Data
- 7.2.3 Product Landscape
- 7.3 Sun Pharmaceutical Industries Limited
- 7.3.1 Business Overview
- 7.3.2 Financial Data
- 7.3.3 Product Landscape
- 7.4 Pfizer
- 7.4.1 Business Overview
- 7.4.2 Financial Data
- 7.4.3 Product Landscape
- 7.5 Sanofi
- 7.5.1 Business Overview
- 7.5.2 Financial Data
- 7.5.3 Product Landscape
- 7.6 Bristol Myers Squibb
- 7.6.1 Business Overview
- 7.6.2 Financial Data
- 7.6.3 Product Landscape
- 7.7 Novartis
- 7.7.1 Business Overview
- 7.7.2 Financial Data
- 7.7.3 Product Landscape
- 7.8 Johnson & Johnson
- 7.8.1 Business Overview
- 7.8.2 Financial Data
- 7.8.3 Product Landscape
- 7.9 GlaxoSmithKline
- 7.9.1 Business Overview
- 7.9.2 Financial Data
- 7.9.3 Product Landscape
- 7.10 Unilever
- 7.10.1 Business Overview
- 7.10.2 Financial Data
- 7.10.3 Product Landscape
- 7.11 Avon Products, Inc
- 7.11.1 Business Overview
- 7.11.2 Financial Data
- 7.11.3 Product Landscape
- 7.12 Beiersdorf
- 7.12.1 Business Overview
- 7.12.2 Financial Data
- 7.12.3 Product Landscape
- 7.13 Henkel AG & Co., KGaA
- 7.13.1 Business Overview
- 7.13.2 Financial Data
- 7.13.3 Product Landscape
- 7.14 Oriflame Holding AG
- 7.14.1 Business Overview
- 7.14.2 Financial Data
- 7.14.3 Product Landscape
- 7.15 The Estee Lauder Companies Inc.
- 7.15.1 Business Overview
- 7.15.2 Financial Data
- 7.15.3 Product Landscape
- 7.16 Yves Rocher
- 7.16.1 Business Overview
- 7.16.2 Financial Data
- 7.16.3 Product Landscape
- 7.17 Shiseido Company, Limited
- 7.17.1 Business Overview
- 7.17.2 Financial Data
- 7.17.3 Product Landscape
- 7.18 Bluebonnet Nutrition
- 7.18.1 Business Overview
- 7.18.2 Financial Data
- 7.18.3 Product Landscape
- 7.19 Barlean's
- 7.19.1 Business Overview
- 7.19.2 Financial Data
- 7.19.3 Product Landscape
- 7.20 Natural Factors
- 7.20.1 Business Overview
- 7.20.2 Financial Data
- 7.20.3 Product Landscape
- 7.21 LifeExtension
- 7.21.1 Business Overview
- 7.21.2 Financial Data
- 7.21.3 Product Landscape